TScan Therapeutics United States of America (USA)
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for TScan Therapeutics published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.12 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.12 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.84 |
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 90.28% Domestic
- 9.72% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with TScan Therapeutics by Share (3 total)
-
TScan Therapeutics and Harvard University
(0.84)
-
TScan Therapeutics and Broad Institute of MIT and Harvard
(0.35)
-
TScan Therapeutics and Massachusetts Institute of Technology (MIT)
(0.23)
Top 10 international collaborators with TScan Therapeutics by Share (1 total)
-
TScan Therapeutics and Immunitrack ApS
(0.15)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.